Liontown (LTR) AGM 2025 summary

Opening remarks and agenda

• Chair welcomed shareholders, acknowledged traditional landowners, including Whadjuk Noongar and Tjiwarl People, and confirmed quorum and voting registration.

• AGM was webcast for remote viewing, with online Q&A enabled, but not a hybrid meeting.

• Directors, executive team, auditors, and Computershare representative were introduced.

Board and executive committee updates

• New executives appointed: COO Ryan Hair, CPO Lisa Breen, and incoming CFO Greg Jason, all bringing significant industry experience.

• Board and executive team credited for positioning the company for long-term growth and successful transition.

• Presentation authorized for release by the Managing Director.

Financial performance review

• FY25 marked the first full year of operations, achieving nearly AUD 300 million in revenue and AUD 55 million in EBITDA.

• 294,521 dmt of concentrate produced and 283,443 dmt sold, with plant availability at 89%.

• Over 360,000 dry metric tons of spodumene concentrate shipped; strong balance sheet with AUD 420 million in cash at quarter end.

• Institutional placement and share purchase plan raised AUD 372 million, supporting transition and growth.

• H2 FY25 unit operating cost was AUD 802 per dmt sold, reflecting ramp-up and market adjustments.